Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionepoxide hydrolase activity

AKR7A3 EPHX2 AKR7L

3.61e-0711273GO:0004301
GeneOntologyMolecularFunctionhydrolase activity, acting on ether bonds

AKR7A3 EPHX2 AKR7L

6.25e-0713273GO:0016801
GeneOntologyMolecularFunctionether hydrolase activity

AKR7A3 EPHX2 AKR7L

6.25e-0713273GO:0016803
GeneOntologyMolecularFunctionphenanthrene-9,10-epoxide hydrolase activity

AKR7A3 AKR7L

5.28e-063272GO:0019119
GeneOntologyMolecularFunctionphenanthrene-epoxide hydrolase activity

AKR7A3 AKR7L

5.28e-063272GO:0019118
GeneOntologyMolecularFunctionaldose reductase (NADPH) activity

AKR7A3 AKR7L

1.59e-0414272GO:0004032
GeneOntologyMolecularFunctionalcohol dehydrogenase (NADP+) activity

AKR7A3 AKR7L

6.05e-0427272GO:0008106
GeneOntologyMolecularFunctionaldo-keto reductase (NADPH) activity

AKR7A3 AKR7L

8.52e-0432272GO:0004033
DomainNADP_OxRdtase_dom

AKR7A3 AKR7L

2.91e-0417282IPR023210
DomainAldo_ket_red

AKR7A3 AKR7L

2.91e-0417282PF00248
DomainAldo/ket_red/Kv-b

AKR7A3 AKR7L

2.91e-0417282IPR001395
DomainZnf_FYVE_PHD

RAG2 CHD4 RPH3A

1.35e-03147283IPR011011
DomainZF_PHD_2

RAG2 CHD4

8.88e-0395282PS50016
DomainZF_PHD_1

RAG2 CHD4

9.06e-0396282PS01359
PathwayWP_AFLATOXIN_B1_METABOLISM

AKR7A3 AKR7L

3.47e-056222MM15846
Pubmed

[Purification of recombinant AKR7A5 protein and measurement of substrate specificity of AKR7A5 towards naphthoquinone and its derivatives].

AKR7A3 AKR7L

1.87e-06328222863590
Pubmed

Aldo-keto reductase 7A5 (AKR7A5) attenuates oxidative stress and reactive aldehyde toxicity in V79-4 cells.

AKR7A3 AKR7L

1.87e-06328224590062
Pubmed

AKR7A5 knockout promote acute liver injury by inducing inflammatory response, oxidative stress and apoptosis in mice.

AKR7A3 AKR7L

1.87e-06328239365156
Pubmed

Novel homodimeric and heterodimeric rat gamma-hydroxybutyrate synthases that associate with the Golgi apparatus define a distinct subclass of aldo-keto reductase 7 family proteins.

AKR7A3 AKR7L

1.87e-06328212071861
Pubmed

Mouse aldo-keto reductase AKR7A5 protects V79 cells against 4-hydroxynonenal-induced apoptosis.

AKR7A3 AKR7L

1.87e-06328216919859
Pubmed

Characterisation of a novel mouse liver aldo-keto reductase AKR7A5.

AKR7A3 AKR7L

1.87e-06328212123834
Pubmed

Aflatoxin B1 aldehyde reductase (AFAR) genes cluster at 1p35-1p36.1 in a region frequently altered in human tumour cells.

AKR7A3 AKR7L

3.75e-06428212879023
Pubmed

Malignant astrocytomas originate from neural stem/progenitor cells in a somatic tumor suppressor mouse model.

RAG2 NF1

9.36e-06628219111880
Pubmed

Identification of Lineage-Specific Transcription Factors That Prevent Activation of Hepatic Stellate Cells and Promote Fibrosis Resolution.

RAG2 NF1

1.31e-05728231982409
Pubmed

CHD4-regulated plasmin activation impacts lymphovenous hemostasis and hepatic vascular integrity.

FGB CHD4

4.10e-051228227140400
Pubmed

The mouse Rhl1 and Rhag genes: sequence, organization, expression, and chromosomal mapping.

AKR7A3 AKR7L

4.10e-051228210495887
Pubmed

Four paralogous protein 4.1 genes map to distinct chromosomes in mouse and human.

AKR7A3 AKR7L

1.18e-04202829828140
Pubmed

In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.

AKR7A3 FGB EPHX2 C1R MAN2B2 AKR7L

1.76e-04107028623533145
Pubmed

Large-scale characterization of HeLa cell nuclear phosphoproteins.

CHD4 NF1 ITSN1 PURB SHCBP1

3.46e-0477428515302935
Pubmed

Identification of candidate alkylator-induced cancer susceptibility genes by whole genome scanning in mice.

FGB TBC1D21

4.09e-043728216707424
Cytoband1p36.13

AKR7A3 AKR7L

5.41e-04562821p36.13
Cytoband12p13

C1R CHD4

7.06e-046428212p13
CoexpressionDESCARTES_ORGANOGENESIS_HEPATOCYTES

FGB EPHX2 C1R FPGS AGMO KLB

1.81e-05535286MM3635
Diseasekidney disease (implicated_via_orthology)

APOL4 KLB

6.47e-0441272DOID:557 (implicated_via_orthology)
Diseasetotal cholesterol measurement, triglyceride measurement, low density lipoprotein cholesterol measurement, high density lipoprotein cholesterol measurement

NF1 RPH3A

9.23e-0449272EFO_0004530, EFO_0004574, EFO_0004611, EFO_0004612
DiseaseNon-alcoholic Fatty Liver Disease

RAG2 KLB

1.87e-0370272C0400966
DiseaseNonalcoholic Steatohepatitis

RAG2 KLB

1.87e-0370272C3241937
Diseasep-tau measurement

MTBP AGMO

1.98e-0372272EFO_0004763
Diseasesquamous cell lung carcinoma, family history of lung cancer

NF1 PURB

2.75e-0385272EFO_0000708, EFO_0006953
Diseasereaction time measurement

COL24A1 TBC1D21 RPH3A PURB

2.86e-03658274EFO_0008393
Diseasealcohol use disorder measurement, alcohol consumption measurement

NF1 KLB

3.56e-0397272EFO_0007878, EFO_0009458
Diseasecoronary artery disease (is_implicated_in)

FGB EPHX2

3.78e-03100272DOID:3393 (is_implicated_in)

Protein segments in the cluster

PeptideGeneStartEntry
GKQPVGRFFGTQWAE

AKR7L

216

Q8NHP1
GKQPVGRFFGNTWAE

AKR7A3

216

O95154
FFNKFSVIFKGPGWG

AGMO

291

Q6ZNB7
PGWTVAGQFQEKKRF

APOL4

21

Q9BPW4
QNGGWENGFVKKFEP

BCL2A1

136

Q16548
GGQKAKMGNFPWQVF

C1R

466

P00736
GQVFFFGQKGWPKRS

RAG2

26

P55895
FGKPNKRRGFSAGLW

HDGFL1

66

Q5TGJ6
DFGRKWDPYKQGFGN

FGB

291

P02675
VQQFKKSGFRGPLNW

EPHX2

451

P34913
FTPGGFVNRFQKWFQ

AWAT2

236

Q6E213
FGEVQGQKGWFPKSY

ITSN1

951

Q15811
NRSGFYWNGVAVFPK

MAN2B2

226

Q9Y2E5
WQKGGIFKQGVPAFT

FPGS

241

Q05932
FPKNFFWGIGTGALQ

KLB

81

Q86Z14
GAKWREFSTNNPFKG

CHD4

206

Q14839
RDFFWKTGNKIGFKP

DERA

241

Q9Y315
NAITVPFKAWGKFGG

PURB

256

Q96QR8
GGIPGSKKWFFAVQA

MTBP

71

Q96DY7
FPGQSSFLWQRGRKF

TOR1AIP2

266

Q8NFQ8
KRSGAWFFKGFPKQV

RPH3A

151

Q9Y2J0
KGKGAGAVQSLFPWF

TBC1D21

226

Q8IYX1
FVGIVGNQFKWNGKG

SHCBP1

651

Q8NEM2
QEKAGWFRFPKLGFS

AHNAK2

5691

Q8IVF2
GFKGWNGQIFKVNTL

COL24A1

1641

Q17RW2
RKGGTFKGFPDWKSF

SPATA31D1

71

Q6ZQQ2
FKCKGTFVGHQGPVW

TRAF7

386

Q6Q0C0
FGFNGLWRFAGPFSK

NF1

2706

P21359